Yohann R.
- Country
- France
- Department
- Hematology
Research Overview
- A phase 3b open-label, multicenter study evaluating physical activity and joint health in previously treated patients ≥12 years of age with severe haemophilia A treated with intravenous recombinant coagulation factor VIII Fc-von Willebrand Factor-XTEN fusion protein (rFVIIIFc-VWF-XTEN; efanesoctocog alfa) for 24 months
- Evaluation of the Efficacy and Safety of Recombinant Von Willebrand Factor with or without Octocog Alfa in Pediatric Severe Hereditary Von Willebrand Disease
- An 18-month low-interventional prospective, multicentre study to assess joint outcomes in patients with haemophilia A or B on prophylaxis with efmoroctocog alfa or eftrenonacog alfa
Data & Insights
Has run more than one trial at 10 of 71 partner sites.
Specializations
Bleeding Disorders
This investigator specializes in studying hereditary blood coagulation disorders, with particular emphasis on both Haemophilia A and B. Their research encompasses evaluating joint health and physical activity outcomes in patients using various therapeutic approaches.
- Joint status assessment
- Physical activity monitoring
- Prophylactic treatment evaluation
Their work includes long-term observational studies spanning 18-24 months to assess treatment effectiveness.
Pediatric Hematology
The investigator focuses on pediatric blood disorders, particularly studying von Willebrand Disease in children under 18 years of age. Their research addresses both surgical and non-surgical bleeding management in pediatric populations.
- Pediatric bleeding management
- Surgical hemostasis
- Treatment safety assessment
Their expertise extends to evaluating hemostatic efficacy in various clinical scenarios.
Therapeutic Innovation
The investigator evaluates novel therapeutic approaches in blood disorders, including research on recombinant factor treatments and their applications in different patient populations.
- Factor replacement therapy
- Prophylactic protocols
- Treatment effectiveness monitoring
Their research encompasses both established and emerging therapeutic options for bleeding disorders.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.